FDA Breast Implant Decisions Cleared By Senate Panel
One year after the U.S. Food and Drug Administration gave two companies conditional approval to market silicone breast implants, a U.S. Senate panel has concluded after conducting an investigation into alleged...To view the full article, register now.
Already a subscriber? Click here to view full article